ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LARRY CRIPE M.D.

Internal Medicine

306

$689K

51
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 25%

$2253
Average prescription price

Avg: $61

RAJ VUPPALANCHI M.D.

Internal Medicine

934

$735K

167
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$787
Average prescription price

Avg: $61

AFIA NAQVI M.D.

Internal Medicine

1,891

$371K

134
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 25%

$196
Average prescription price

Avg: $61

JAMES GAITHER M.D.

Internal Medicine

449

$85.1K

63
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

40%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$189
Average prescription price

Avg: $61

ANDREW FISCHER M.D.

Internal Medicine

808

$139K

120
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

74%
prescriptions for brand name drugs

Avg: 25%

$172
Average prescription price

Avg: $61

KRISTINE REA MD

Internal Medicine

3,425

$588K

276
142 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

34%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$172
Average prescription price

Avg: $61

ERIK IMEL M.D.

Internal Medicine

231

$34.9K

24
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$151
Average prescription price

Avg: $61

MOHAMMAD TAVASSOLI D.O

Internal Medicine

517

$75.6K

139
56 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

38%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 25%

$146
Average prescription price

Avg: $61

CANDICE FLAUGHER DO

Internal Medicine

3,450

$491K

399
221 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$142
Average prescription price

Avg: $61

RAJEEV MEHTA MD

Internal Medicine

2,625

$366K

425
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 25%

$139
Average prescription price

Avg: $61

MADELAINE SGROI DO

Internal Medicine

664

$80.2K

119
98 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $61

RADOSVETA IVANOVA NESCH M.D.

Internal Medicine

2,146

$254K

122
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $61

ROY POLLOM MD

Internal Medicine

3,952

$467K

212
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $61

STEVEN GOLDSTEIN MD

Internal Medicine

19,692

$2.33M

704
445 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $61

WILLIAM SCHMALZ MD

Internal Medicine

11,756

$1.35M

475
404 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $61

NAPOLEON MAMINTA DO

Internal Medicine

8,607

$985K

309
270 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$114
Average prescription price

Avg: $61

ANTOINETTE MENSAH MD

Internal Medicine

1,052

$119K

144
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$113
Average prescription price

Avg: $61

GASTON DANA DO

Internal Medicine

4,180

$473K

361
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$113
Average prescription price

Avg: $61

JOSEPH DICKEY M.D.

Internal Medicine

5,739

$620K

331
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $61

EROMONSELE IDAHOSA MD

Internal Medicine

842

$90.8K

71
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

39%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $61

VIVEK SAHGAL M.D., FACP

Internal Medicine

3,531

$380K

126
61 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $61

FRED FRICK MD

Internal Medicine

5,767

$620K

376
292 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$107
Average prescription price

Avg: $61

TIMOTHY STORY MD

Internal Medicine

2,213

$235K

80
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$106
Average prescription price

Avg: $61

ALEXANDER GATZIMOS M.D.,JD

Internal Medicine

4,926

$518K

219
115 are 65+

25%
patients receiving schedule two controlled substances

Avg: 6%

33%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $61

SOHAIL USMAN MD

Internal Medicine

947

$98.2K

132
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank